Pfizer (PFE) News Today → “This will be one of the biggest revolutions ever.” - NVIDIA CEO (From Behind the Markets) (Ad) Free PFE Stock Alerts $28.66 +0.46 (+1.63%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 6:11 PM | marketbeat.comClark Estates Inc. NY Sells 84,700 Shares of Pfizer Inc. (NYSE:PFE)Clark Estates Inc. NY cut its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 40.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 123,025 shares of the biopharmaceutical company's stock after selling 84,700 sharesJune 1 at 8:00 AM | businesswire.comTakeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin LymphomaJune 1 at 8:00 AM | businesswire.comPfizer's ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)June 1 at 3:00 AM | fool.comIs Pfizer the Best Dividend Stock for You?May 31 at 10:41 PM | marketbeat.comRichard C. Young & CO. LTD. Cuts Holdings in Pfizer Inc. (NYSE:PFE)Richard C. Young & CO. LTD. lessened its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 50.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 193,381 shares of the biopharmaceuticalMay 31 at 9:03 PM | benzinga.comPfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung CancerMay 31 at 2:42 PM | marketbeat.comPfizer (NYSE:PFE) Trading Up 1.6%Pfizer (NYSE:PFE) Shares Up 1.6%May 31 at 9:00 AM | cnbc.comPfizer's drug for advanced lung cancer shows promising long-term trial resultsMay 31 at 8:10 AM | reuters.comPfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year dataMay 31 at 8:00 AM | businesswire.comPfizer's LORBRENA® CROWN Study Shows Majority of Patients with ALK-Positive Advanced Lung Cancer Living Beyond Five Years Without Disease ProgressionMay 31 at 6:30 AM | reuters.comEU regulator recommends use of Pfizer's gene therapy for rare bleeding disorderMay 31 at 3:30 AM | fool.comIs Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?May 31 at 12:49 AM | marketbeat.comArrow Financial Corp Sells 40,673 Shares of Pfizer Inc. (NYSE:PFE)Arrow Financial Corp lessened its position in Pfizer Inc. (NYSE:PFE - Free Report) by 48.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 42,940 shares of the biopharmaceutical company's stock after selling 40,673 shares duriMay 30 at 2:45 PM | cnbc.comHealthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conferenceMay 30 at 1:45 PM | marketbeat.comPfizer (NYSE:PFE) Shares Up 0.3%Pfizer (NYSE:PFE) Stock Price Up 0.3%May 30 at 5:45 AM | fool.com3 Dividend Stocks to Double Up on Right NowMay 30 at 12:10 AM | marketbeat.comCatalytic Wealth RIA LLC Acquires New Shares in Pfizer Inc. (NYSE:PFE)Catalytic Wealth RIA LLC acquired a new stake in Pfizer Inc. (NYSE:PFE - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The fund acquired 35,465 shares of the biopharmaceutical company's stock, valued at approximately $1,021,000. Other hedge funds have also boMay 29 at 2:30 PM | marketbeat.comPfizer (NYSE:PFE) Trading Down 2%Pfizer (NYSE:PFE) Shares Down 2%May 29 at 9:31 AM | investorplace.com7 Must-Own Stocks to Hold for the Second Half of 2024May 29 at 6:04 AM | americanbankingnews.comPfizer (NYSE:PFE) Trading Up 0.7%May 29 at 12:50 AM | marketbeat.comBruce & Co. Inc. Has $7.73 Million Stake in Pfizer Inc. (NYSE:PFE)Bruce & Co. Inc. decreased its holdings in Pfizer Inc. (NYSE:PFE - Free Report) by 48.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 268,500 shares of the biopharmaceutical company's stock after selling 251May 28, 2024 | marketbeat.comPfizer (NYSE:PFE) Shares Down 2% Pfizer (NYSE:PFE) Stock Price Down 2%May 28, 2024 | investorplace.comRevenge of the Apes: 3 Reddit WallStreetBets Stocks That Could Pop NextMay 28, 2024 | markets.businessinsider.comBerenberg Bank Reaffirms Their Hold Rating on Pfizer (PFE)May 28, 2024 | fool.com2 Beaten-Down Dividend Stocks Near 52-Week Lows. Should You Buy the Dips?May 27, 2024 | marketbeat.comEdmond DE Rothschild Holding S.A. Has $75.20 Million Holdings in Pfizer Inc. (NYSE:PFE)Edmond DE Rothschild Holding S.A. raised its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 13.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,611,864 shares of the biopharmaceuticalMay 27, 2024 | investorplace.comDividend Deals: 3 Overlooked Stocks Offering Incredible ValueMay 27, 2024 | marketbeat.comPfizer (NYSE:PFE) Shares Up 0.7%Pfizer (NYSE:PFE) Shares Up 0.7%May 27, 2024 | investing.comPfizer Stock: Chart Indicates a Long-Term Bottom , But Is the Dividend Safe?May 27, 2024 | seekingalpha.comPfizer: The Chart Looks Like A Bottom, But Is The Dividend Safe?May 26, 2024 | marketbeat.comCantor Fitzgerald Investment Advisors L.P. Takes Position in Pfizer Inc. (NYSE:PFE)Cantor Fitzgerald Investment Advisors L.P. acquired a new position in shares of Pfizer Inc. (NYSE:PFE - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 561,526 shares of the biopharmaceuticalMay 26, 2024 | fool.comGot $500? 3 Pharma Stocks to Buy and Hold ForeverMay 26, 2024 | fool.comHow Much Will Pfizer Pay Out in Dividends This Year?May 26, 2024 | americanbankingnews.comPfizer (NYSE:PFE) Stock Price Up 0.1%May 25, 2024 | marketbeat.comPfizer Inc. (NYSE:PFE) Shares Acquired by Intech Investment Management LLCIntech Investment Management LLC raised its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 61.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 509,488 shares of the biopharmaceutical company's stock after acMay 25, 2024 | fool.com1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold ForeverMay 25, 2024 | americanbankingnews.comEquities Analysts Issue Forecasts for Pfizer Inc.'s Q3 2025 Earnings (NYSE:PFE)May 25, 2024 | marketbeat.comJohnson Financial Group Inc. Trims Stock Position in Pfizer Inc. (NYSE:PFE)Johnson Financial Group Inc. cut its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 43.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 79,371 shares of the biopharmaceutical company's stock after sellMay 24, 2024 | finance.yahoo.comInvest $50k In This Stock To Become A Dividend Millionaire In 10 YearsMay 24, 2024 | marketbeat.comPfizer (NYSE:PFE) Shares Up 0.1%Pfizer (NYSE:PFE) Trading 0.1% HigherMay 24, 2024 | seekingalpha.comPfizer: Down To A Historically Low Valuation - Is It A Buy?May 24, 2024 | marketbeat.comZacks Research Equities Analysts Decrease Earnings Estimates for Pfizer Inc. (NYSE:PFE)Pfizer Inc. (NYSE:PFE - Free Report) - Investment analysts at Zacks Research dropped their Q3 2025 earnings per share estimates for shares of Pfizer in a research report issued to clients and investors on Wednesday, May 22nd. Zacks Research analyst K. Shah now anticipates that the biopharmaceuticMay 24, 2024 | fool.com3 Stocks That Can Help You to Get Richer in 2025 and BeyondMay 24, 2024 | marketbeat.comPfizer Inc. (NYSE:PFE) Stock Holdings Lifted by Greylin Investment Management IncGreylin Investment Management Inc lifted its holdings in shares of Pfizer Inc. (NYSE:PFE - Free Report) by 43.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 249,672 shares of the biopharmaceutical company's sMay 23, 2024 | msn.comPfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost ReductionsMay 23, 2024 | marketbeat.comPfizer (NYSE:PFE) Shares Down 2.3% Pfizer (NYSE:PFE) Trading Down 2.3%May 23, 2024 | investorplace.comThe Savvy Investor's Cheat Sheet: 3 Deep Value Picks for May 2024May 23, 2024 | investorplace.com3 Biotech Stocks to Buy on the Dip: May 2024May 23, 2024 | msn.comPfizer Aims to Save Billions in Cut CostsMay 23, 2024 | msn.comPfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. PFE Media Mentions By Week PFE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.680.78▲Average Medical News Sentiment PFE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼3635▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Johnson & Johnson News Merck & Co., Inc. News AbbVie News Bristol-Myers Squibb News Zoetis News Royalty Pharma News Jazz Pharmaceuticals News Perrigo News Corcept Therapeutics News Supernus Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
